PRECURSOR N-ACETYLGALACTOSAMINE-4-SULFATASE, METHODS OF TREATMENT USING SAID ENZYME AND METHODS FOR PRODUCING AND PURIFYING SAID ENZYME

The present invention provides a highly purified recombinant human precursor N --acetylgalactosamine-4-sulfatase and biologically active mutants, fragments and analogs thereof as well as pharmaceutical formulations comprising highly purified recombinant human precursor N-acetylgalactosamine-4-sulfat...

Full description

Saved in:
Bibliographic Details
Main Author STUART SWEIDLER
Format Patent
LanguageEnglish
Spanish
Published 22.07.2005
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides a highly purified recombinant human precursor N --acetylgalactosamine-4-sulfatase and biologically active mutants, fragments and analogs thereof as well as pharmaceutical formulations comprising highly purified recombinant human precursor N-acetylgalactosamine-4-sulfatase. The invention also provides methods for treating diseases caused all or in part by deficiencies in human N-acetylgalactosamine-4 --sulfatase including MPS VI and methods for producing and purifying the recombinant precursor enzyme to a highly purified form. La presente invencion proporciona una N-acetilgalactosamina-4-sulfatasa precursora recombinante humana altamente purificada y mutantes, fragmentos y analogos biologicamente activos de la misma asi como formulaciones farmaceuticas que comprenden N-acetilgalactosamina-4-sulfatasa precursora recombinante humana. La invencion tambien proporciona metodos para tratar enfermedades ocasionadas totalmente o en parte por deficiencias en N-acetilgalactosamina-4-sulfatasa humana incluyendo MPS VI y metodos para producir y purificar la enzima precursora recombinante a una forma altamente purificada.
Bibliography:Application Number: MX2005PA04880